Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
140
Participants
Timeline
Start Date
June 30, 2014
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
Conditions
Healthy Adults
Interventions
DRUG
BMS-986089
DRUG
Placebo matching with BMS-986089
Trial Locations (1)
90630
Wcct Global, Llc, Cypress
All Listed Sponsors
lead
Hoffmann-La Roche
INDUSTRY
NCT02145234 - Placebo-Controlled, Single and Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986089 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter